Abortion

Legislators must come together to protect pregnant patients who miscarry.

Political pressure and wary regulators shaped FDA’s mifepristone approval in 2000.

Scholars discuss EMTALA’s effects on physicians and argue for its continued use.

The Supreme Court must maintain pregnant people’s right to receive emergency medical care—including abortion.

By second-guessing FDA safety determinations, the Fifth Circuit challenges the Supreme Court to restore agency deference.

Scholar argues that ERISA limits states’ ability to restrict abortion access.

Scholar calls for FDA to remove stringent restrictions on medication abortion.

Scholars consider how the authorization of telehealth can expand access to medication abortion.

President Biden announces nominee to head OIRA, a federal judge blocks coverage of HIV prevention drugs, and more…

Following the Supreme Court’s decision overturning Roe v. Wade, experts discuss abortion-related data privacy concerns.

The majority’s reasoning in Dobbs v. Jackson Women’s Health entrenches the historical failures of the United States.

Scholars and practitioners discuss the Court’s most significant regulatory decisions of the last term.